| Health / Medical Topics |
Immunotherapeutic GSK1572932A
An immunotherapeutic containing a proprietary adjuvant system combined with a melanoma-associated antigen peptide MAGE-A3 epitope with potential immunomodulating and antineoplastic activities. Intramuscular administration with GSK1572932A may stimulate the immune system to exert both humoral and cellular immune responses against MAGE-A3-expressing tumor cells. MAGE-A3, a tumor associated antigen (TAA), is overexpressed in a variety of tumor cell types, including non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, and bladder cancer. (NCI Thesaurus)
YOU MAY ALSO LIKE
Therapy used to decrease the body's immune responses, such as drugs given to prevent transplant rejection.
An Immunosuppressive Effect involves interference with, or restraint of, the function of biologic molecules and complexes, or cellular, cell, or tissue components…
An agent that decreases the body’s immune responses. It reduces the body’s ability to fight infections and other diseases, such as…
Describes the ability to decrease the body's immune system responses.
Suppression of the body's immune system and its ability to fight infections and other diseases. Immunosuppression may be deliberately induced with drugs,…
An agent that decreases the body’s immune responses. It reduces the body’s ability to fight infections and other diseases, such as…
